Webform | 2022.09.12
Document de presse | 2022.09.05
The memory system alternates between periods of learning and remembering. These two functions are controlled by different neural circuits. Using an animal model, scientists from the Institut Pasteur recently identified a neural signal in the hippocampus, a brain region essential for forming and recalling memories, that enables the brain to alternate between remembering and learning modes. The...
Portrait | 2022.09.22
It's hard to miss this pair on the Institut Pasteur campus in Paris. Obviously they're twins, but there's more to them than that. Even a brief encounter with these two characters gives a sense of their energy, curiosity and abundant optimism. Full of enthusiasm, they take turns to tell us about the unique journey that led to them completing their theses at the Institut Pasteur. These determined,...
Article | 2022.09.26
Promotion PPU 2022-2025PhD studentUndergraduate studiesLaboratoryPhD DirectorLab HeadPhD ProjectDoctoral schoolPPU studentsBERGMAN AlexanderUppsala University, Uppsala, SwedenInsect-Virus InteractionsLAMBRECHTS LouisLAMBRECHTS LouisTransposable elements and antiviral defense in the mosquito Aedes aegyptiCdV ED515BORDA BOSSANA StefanoUniversity of Trieste,Trieste, ItalyDynamic Neuronal...
Document de presse | 2022.10.10
The purpose of anesthesia is to put the brain into an unconscious state in which stimuli such as sounds are not perceived. In this state, the neurons in the auditory cortex are still stimulated by sounds, but the latter are not perceived by the brain. Scientists from the Institut Pasteur, the CNRS and Université Paris-Saclay have revealed a novel neural mechanism that accompanies the transition...
News | 2022.10.19
The Institut Pasteur and INRAE are strengthening their partnership to tackle infectious and toxic risks and prevent zoonotic diseases. Christophe d'Enfert, Senior Executive Scientific Vice-President at the Institut Pasteur, tells us about the importance of this partnership that focuses on the biology of living systems with the aim of improving animal and human health.
Page avancée | 2022.10.25
Our Sars-Cov-2 research projects
Document de presse | 2022.10.19
Researchers from the Institut Pasteur, McMaster University and the University of Chicago have identified genes that protected some individuals against the devastating bubonic plague pandemic that swept through Europe, Asia and Africa nearly 700 years ago. The same genes that once conferred protection against the Black Death are today associated with an increased susceptibility to autoimmune...
Document de presse | 2022.10.21
SPK001, the first anti-SARS Cov2 monoclonal antibody candidate of SpikImm, a French biotechnology company founded by Truffle Capital, originally discovered by the Institut Pasteur's Human Immunology Laboratory, directed by Dr. Hugo Mouquet (Inserm Joint Research Unit), has been tested on three initial cohorts of healthy volunteers, and has demonstrated excellent tolerance, in the context of the...
Document de presse | 2022.10.30
Two Academic and Scientific Heavyweights Agree to Implement Joint Actions Towards the Creation of a Center of Excellence in Emerging Infectious Diseases with Planned Operations/Locations in Paris and San Francisco. In a ceremony on October 21, 2022, the Institut Pasteur and UC San Francisco Quantitative Biosciences Institute (UCSF QBI) announced a new partnership for the joint establishment...